| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.04 |